RNA5SP461

Across TCGA pan-cancer cohorts, RNA5SP461 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated RNA5SP461 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNA5SP461 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNA5SP461 expression acts as an unfavorable survival marker.

STAD, BRCA, and KIRC are the cancer types where RNA5SP461 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	All	0.202	0.590	<.001	99	view →
BRCA	OS	Tertile	All	0.115	0.579	<.001	60	view →
KIRC	DFS	Tertile	III,IV	0.156	0.643	.015	36	view →
UCEC	OS	Tertile	All	0.610	0.928	.004	30	view →
SKCM	DFS	Tertile	All	0.073	0.739	<.001	18	view →
HNSC	OS	Tertile	All	0.262	0.686	.036	9	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

RNA5SP461–STAD (OS)

Open the STAD breakdown →